HRZE Dosing with Creatinine Clearance of 63 mL/min
With a creatinine clearance of 63 mL/min, you should use standard daily doses for isoniazid (H), rifampin (R), and pyrazinamide (Z), but adjust ethambutol (E) dosing to three times weekly at 15-20 mg/kg after ensuring adequate drug levels. This patient has mild-to-moderate renal impairment (CrCl 63 mL/min falls in the 50-70 mL/min range), which primarily affects ethambutol clearance.
Drug-Specific Dosing Recommendations
Isoniazid (H)
- Standard dose: 300 mg daily (5 mg/kg) 1
- No adjustment needed for CrCl 63 mL/min
- Give supplemental dose after dialysis only if patient progresses to hemodialysis 1
Rifampin (R)
- Standard dose: 600 mg daily (10 mg/kg) 1
- No adjustment needed for CrCl 63 mL/min
- Rifampin dosing remains 50-100% of full dose even with CrCl 10-50 mL/min 1
Pyrazinamide (Z)
- Standard dose: 25-30 mg/kg daily 1
- No adjustment needed for CrCl 63 mL/min
- Dose reduction only required when CrCl <10 mL/min (50-100% of full dose) 1
Ethambutol (E)
- Adjust to 15-20 mg/kg three times weekly 2
- This is the critical adjustment for CrCl 63 mL/min
- Ethambutol requires dose/interval adjustment when CrCl <70 mL/min 3, 2
- The risk of optic toxicity increases significantly with renal impairment due to drug accumulation 2
Clinical Reasoning
The key distinction here is that ethambutol is primarily renally cleared, while the other three drugs are predominantly hepatically metabolized 2. The guideline evidence clearly states that ethambutol dosing should be adjusted when creatinine clearance falls below 70 mL/min 3, 2. Your patient at 63 mL/min falls just below this threshold.
Standard regimen structure remains: 2 months intensive phase (HRZE) followed by 4 months continuation phase (HR) 2. The total duration is still 6 months for drug-susceptible pulmonary TB 2.
Monitoring Requirements
- Visual acuity testing monthly while on ethambutol, given the increased risk of optic neuritis with renal impairment 2
- Monitor renal function every 2-4 weeks during intensive phase
- If CrCl declines further below 50 mL/min, consider reducing pyrazinamide frequency to three times weekly 1
- Watch for hyperuricemia with pyrazinamide, as risk increases with declining renal function 2
Common Pitfall
Do not empirically reduce all four drugs based on mild renal impairment. Only ethambutol requires adjustment at this level of renal function. Underdosing rifampin or isoniazid risks treatment failure and acquired drug resistance, which would be catastrophic for both the patient and public health.